What does Amgen specialize in?

What does Amgen specialize in?

We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Our medicines typically address diseases for which there are limited treatment options, or they are medicines that provide a viable option to what is otherwise available.

What company did Amgen buy?

Immunex Corporation
THOUSAND OAKS, Calif. – July 16, 2002 – Amgen Inc. (Nasdaq: AMGN), the world’s largest biotechnology company, announced today that it has completed its acquisition of Immunex Corporation (Nasdaq: IMNX), a leader in inflammation and one of biotechnology’s premier companies.

Is Amgen competitive?

Amgen’s revenue is the ranked 13th among it’s top 10 competitors. The top 10 competitors average 31.9B. Over the last four quarters, Amgen’s revenue has grown by 96.8%.

What biotech techniques does Amgen use?

Amgen now uses a proprietary expression system using unique plasmid vectors—loops of DNA that combine the product gene with expression-enhancing genes. This system allows us to pressure the cells into making multiple copies of our product gene, effectively transforming the cells into medicine-making machines.

Who is the CEO of Amgen?

Robert A. Bradway (May 23, 2012–)

Is Amgen a good company to work for?

Amgen leapt from last year’s No. 20 ranking to the No. 3 spot on Business Insider’s just released annual list of the best companies to work for in America . When looking specifically at the best companies in healthcare to work for, Amgen ranked No.

Who competes with AbbVie?

AbbVie competitors include Johnson & Johnson, Roche, Merck and Pfizer. AbbVie ranks 1st in CEO Score on Comparably vs its competitors.

How long has Amgen been in business?

2020. Over 40 years, Amgen grew from a small team in a California office park to a global biotech leader in approximately 100 countries. Hundreds of biotech companies have come and gone since our founding in 1980, but Amgen is still here, and we’re stronger than ever.

How much does the CEO of Amgen make?

Bradway, the CEO of Amgen, earned $20.13 million in total compensation in 2020 — 3% more than he earned in 2019, and 8.23% more than in 2018. His base pay only increased $500,000, while most of the increase in his salary came from stock options.

How much does an executive director at Amgen make?

Average Amgen Executive Director yearly pay in the United States is approximately $287,007, which is 256% above the national average.

What was the value of Amgen stock at the time of its IPO?

Since its initial public offering (IPO), the stock has split five times. If you had invested $1,000 at the time of Amgen’s IPO, your investment would have grown to be worth $606,700 as of Sept. 2018 without reinvesting dividends. This is a compound annual growth rate (CAGR) of over 20%.

How much money does Amgen spend on are & D?

Amgen has a long history of investing aggressively in R&D (last year the spending was a hefty $4 billion). The result is that the company has been building a solid portfolio of drugs. Note that six generate more than $500 million a year.

What was the purpose of the company Amgen?

The History of Amgen. Amgen began as AMGen, which stood for Applied Molecular Genetics, in 1980. In the early years, the company attempted a wide variety of scientific breakthroughs, such as organisms that could extract oil from shale, cloning the light source of fireflies, making specialty chemicals and growing chickens faster.

How is Amgen making a difference in the world?

Amgen is a pioneer in the science of using living cells to make biologic medicines. Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.